Get frequent FDA email updates delivered on this matter to the inbox. Enter your e-mail deal with to subscribe:Adequate and properly-managed scientific studies have failed to exhibit a threat on the fetus in the 1st trimester of pregnancy (and there is no proof of threat in afterwards trimesters).Improved pricing transparency: Requiring pharmaceuti